peter attia on semaglutide Could GLP-1s impact aging and cognitive health? Semaglutide VS Tirzepatide: What are

In the present narrative review, we will provide the reader with a practical summary of available evidence and guideline recommendations on screening, diagnosis, and treatment of NAFLD/MASLD in patients with T2D

Phase 2 data, whilst promising, does not constitute sufficient evidence for clinical use outside of a research context

CD is usually diagnosed through serological testing for the presence of specific antibodies

317 It has been shown that fatty acids strongly enhance GIP secretion, and this hormone then subsequently plays an important role in mediating fat uptake into adipose tissue

For type 2 diabetes, tirzepatide starts at 2.5 mg subcutaneously once weekly for four weeks, then increases by 2.5 mg increments every four weeks as tolerated, per the Mounjaro prescribing information

Results from EXAMINE, SAVOR-TIMI53, and TECOS also shed some light on HF